These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38428685)
1. Nicotinamide phosphoribosyltransferase modulates PD-L1 in bladder cancer and enhances immunotherapeutic sensitivity. Chen KC; Dhar T; Chen CR; Chen EC; Peng CC Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167106. PubMed ID: 38428685 [TBL] [Abstract][Full Text] [Related]
2. Local Targeting of NAD Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997 [TBL] [Abstract][Full Text] [Related]
3. Targeting the NAD Ye C; Qi L; Li X; Wang J; Yu J; Zhou B; Guo C; Chen J; Zheng S Cell Commun Signal; 2020 Jan; 18(1):16. PubMed ID: 32005247 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells. Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913 [TBL] [Abstract][Full Text] [Related]
5. NAD Lv H; Lv G; Chen C; Zong Q; Jiang G; Ye D; Cui X; He Y; Xiang W; Han Q; Tang L; Yang W; Wang H Cell Metab; 2021 Jan; 33(1):110-127.e5. PubMed ID: 33171124 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma. Wang XY; Wang JZ; Gao L; Zhang FY; Wang Q; Liu KJ; Xiang B Toxicol Appl Pharmacol; 2017 Sep; 331():54-61. PubMed ID: 28501332 [TBL] [Abstract][Full Text] [Related]
7. Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer. Liu HY; Wang FH; Liang JM; Xiang YY; Liu SH; Zhang SW; Zhu CM; He YL; Zhang CH J Cancer Res Clin Oncol; 2023 Jul; 149(7):2743-2756. PubMed ID: 35776198 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress. Sharma P; Xu J; Williams K; Easley M; Elder JB; Lonser R; Lang FF; Lapalombella R; Sampath D; Puduvalli VK Neuro Oncol; 2022 Feb; 24(2):229-244. PubMed ID: 34260721 [TBL] [Abstract][Full Text] [Related]
10. Oleate ameliorates palmitate-induced reduction of NAMPT activity and NAD levels in primary human hepatocytes and hepatocarcinoma cells. Penke M; Schuster S; Gorski T; Gebhardt R; Kiess W; Garten A Lipids Health Dis; 2017 Oct; 16(1):191. PubMed ID: 28974242 [TBL] [Abstract][Full Text] [Related]
11. The NAD(+) salvage pathway modulates cancer cell viability via p73. Sharif T; Ahn DG; Liu RZ; Pringle E; Martell E; Dai C; Nunokawa A; Kwak M; Clements D; Murphy JP; Dean C; Marcato P; McCormick C; Godbout R; Gujar SA; Lee PW Cell Death Differ; 2016 Apr; 23(4):669-80. PubMed ID: 26586573 [TBL] [Abstract][Full Text] [Related]
13. Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle-dependent in mammalian cells, and its inhibition slows cell growth. Svoboda P; Krizova E; Sestakova S; Vapenkova K; Knejzlik Z; Rimpelova S; Rayova D; Volfova N; Krizova I; Rumlova M; Sykora D; Kizek R; Haluzik M; Zidek V; Zidkova J; Skop V J Biol Chem; 2019 May; 294(22):8676-8689. PubMed ID: 30975903 [TBL] [Abstract][Full Text] [Related]
14. NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms. Zhang XQ; Lu JT; Jiang WX; Lu YB; Wu M; Wei EQ; Zhang WP; Tang C Neuroscience; 2015 Apr; 291():230-40. PubMed ID: 25684751 [TBL] [Abstract][Full Text] [Related]
15. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. Soncini D; Caffa I; Zoppoli G; Cea M; Cagnetta A; Passalacqua M; Mastracci L; Boero S; Montecucco F; Sociali G; Lasigliè D; Damonte P; Grozio A; Mannino E; Poggi A; D'Agostino VG; Monacelli F; Provenzani A; Odetti P; Ballestrero A; Bruzzone S; Nencioni A J Biol Chem; 2014 Dec; 289(49):34189-204. PubMed ID: 25331943 [TBL] [Abstract][Full Text] [Related]
16. Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE. Bruzzone S; Fruscione F; Morando S; Ferrando T; Poggi A; Garuti A; D'Urso A; Selmo M; Benvenuto F; Cea M; Zoppoli G; Moran E; Soncini D; Ballestrero A; Sordat B; Patrone F; Mostoslavsky R; Uccelli A; Nencioni A PLoS One; 2009 Nov; 4(11):e7897. PubMed ID: 19936064 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-26b Reduces Cell Viability by Inhibition of Nicotinamide Phosphoribosyltransferase in Breast Cancer Cells. Ameli Mojarad M; Ameli Mojarad M; Pourmahdian A DNA Cell Biol; 2022 Aug; 41(8):735-741. PubMed ID: 35792597 [TBL] [Abstract][Full Text] [Related]
18. Intracellular NAMPT-NAD+-SIRT1 cascade improves post-ischaemic vascular repair by modulating Notch signalling in endothelial progenitors. Wang P; Du H; Zhou CC; Song J; Liu X; Cao X; Mehta JL; Shi Y; Su DF; Miao CY Cardiovasc Res; 2014 Dec; 104(3):477-88. PubMed ID: 25341895 [TBL] [Abstract][Full Text] [Related]
19. Discovery of potent NAMPT-Targeting PROTACs using FK866 as the warhead. Zhang P; Wang W; Guo M; Zhou L; Dong G; Xu D; Sheng C Bioorg Med Chem Lett; 2023 Aug; 92():129393. PubMed ID: 37369332 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD Ratia KM; Shen Z; Gordon-Blake J; Lee H; Laham MS; Krider IS; Christie N; Ackerman-Berrier M; Penton C; Knowles NG; Musku SR; Fu J; Velma GR; Xiong R; Thatcher GRJ Biochemistry; 2023 Feb; 62(4):923-933. PubMed ID: 36746631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]